Your browser doesn't support javascript.
loading
Does the Effectiveness and Mechanical Strength of Kanamycin-Loaded Bone Cement in Musculoskeletal Tuberculosis Compare to Vancomycin-Loaded Bone Cement.
Lee, Jae Hoo; Shin, Sung Jae; Cho, Sang-Nae; Baek, Seung-Hun; Kim, Do Hyun; Park, Kwan Kyu.
Affiliation
  • Lee JH; Department of Orthopaedic Surgery, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
  • Shin SJ; Department of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Cho SN; Department of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Baek SH; Department of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim DH; Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Park KK; Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
J Arthroplasty ; 35(3): 864-869, 2020 03.
Article in En | MEDLINE | ID: mdl-31708292
ABSTRACT

BACKGROUND:

Antibiotic-loaded bone cement (ALBC) is used to deliver antimycobacterial agents into the focal lesion of musculoskeletal tuberculosis. Although kanamycin is currently used as an antimycobacterial agent for the treatment of multidrug-resistant tuberculosis, there is no information about its suitability in ALBC.

METHODS:

An in vitro experiment was conducted with cylindrical shape of 40 g of bone cement with 1, 2, and 3 g of kanamycin. Eluate (1 mL) was extracted from each specimen to measure the level of elution and antimycobacterial activity on days 1, 4, 7, 14, and 30. The quantity of kanamycin in eluates was evaluated by a liquid chromatography-mass spectrometry system, and the antimycobacterial activity of eluates against Mycobacterium tuberculosis H37Rv was calculated by comparing the minimal inhibitory concentration. The ultimate compression strength was conducted using a material testing system machine (Instron 3366; Instron, Norwood, MA) before and after elution.

RESULTS:

Eluates from ALBC containing 2 and 3 g of kanamycin had effective antimycobacterial activity for 30 days, whereas eluates from ALBC containing 1 g of kanamycin were partially active until day 30. The pre-eluted compression strength of kanamycin-loaded cement and vancomycin-loaded cement was weaker as they contained a larger amount of antibiotics. There was no statistical difference between the strength of all kanamycin regimens and 1 g of vancomycin in the ultimate compression test. After 30 days of elution, the strength of all kanamycin-loaded cement and vancomycin-loaded cement cylinders was significantly lower than that of initial specimens (P < .05).

CONCLUSION:

The antimycobacterial activity of ALBC containing more than 2 g of kanamycin was effective during a 30-day period. The ultimate compression strength of bone cement loaded with 1-3 g of kanamycin was comparable with 1 g of vancomycin while maintaining effective elution until day 30.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Tuberculosis / Vancomycin Limits: Humans Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Tuberculosis / Vancomycin Limits: Humans Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2020 Type: Article